Ariad's NFkappaB patent claims shot down on appeal.
Garber
Ken
K
D004345:Drug Industry / Q000331:legislation & jurisprudence*; D016328:NF-kappa B; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D011486:Protein C; D020849:Raloxifene Hydrochloride; D011994:Recombinant Proteins; D015398:Signal Transduction; D014495:Universities / Q000331:legislation & jurisprudence
D016328:NF-kappa B; D011486:Protein C; D011994:Recombinant Proteins; D020849:Raloxifene Hydrochloride; C421124:drotrecogin alfa activated